Valuation : Sinocare Inc.

Market Cap 8.57B 1.28B 1.1B 1.04B 943M 1.77B 121B 1.78B 12.24B 4.76B 61.59B 4.79B 4.69B 204B P/E 2026 *
22.8x
P/E 2027 * 19x
Enterprise Value 8.57B 1.28B 1.1B 1.04B 943M 1.77B 121B 1.78B 12.24B 4.76B 61.59B 4.79B 4.69B 204B EV / Sales 2026 *
1.69x
EV / Sales 2027 * 1.54x
Free-Float
50.69%
Yield 2026 *
1.4%
Yield 2027 * 1.55%
1 day+0.75%
1 week-1.47%
Current month+0.75%
1 month-1.65%
3 months+2.29%
6 months-9.76%
Current year-6.02%
1 week 15.88
Extreme 15.88
16.26
1 month 15.6
Extreme 15.6
16.84
Current year 13.37
Extreme 13.37
20.32
1 year 13.37
Extreme 13.37
21.64
3 years 13.37
Extreme 13.37
35.46
5 years 13.3
Extreme 13.3
39.21
10 years 9.62
Extreme 9.62
53.69
Manager TitleAgeSince
Chief Executive Officer 36 2025-12-30
Director of Finance/CFO 52 2023-12-28
Compliance Officer 42 2016-01-31
Director TitleAgeSince
Chairman 61 2010-12-02
Director/Board Member 53 2015-09-24
Director/Board Member 42 2017-04-24
Date Insider Type Main position Quantity % Market Cap. Importance
1/30/26 Buy

Chief Executive Officer

571,800 0.1256%
3/16/25 Buy 62,600 0.0137%
1/12/21 Sell

Chairman

11,600 0.0027%
Change 5-day change 1-year change 3-year change Capi.($)
+0.75%-1.47%-23.28%-33.77% 1.28B
-1.30%-6.20%-17.89%+5.91% 188B
+1.53%+0.99%-0.83%+12.07% 118B
+2.28%+0.89%+13.50%+89.17% 63.16B
-1.69%-1.96%+26.49%+48.87% 52.01B
-0.53%-1.40%-3.04%-32.80% 50.97B
-1.01%+1.10%+19.64%-11.54% 34.02B
+0.23%-1.49% - - 30.8B
-0.72%-2.82%+37.13%-16.93% 23.83B
-2.65%-3.71%-7.09%+14.02% 23.45B
Average -0.31%-1.55%+4.96%+8.33% 58.58B
Weighted average by Cap. -0.24%-2.60%-0.07%+15.36%

Financials

2026 *2027 *
Net sales 5.06B 753M 649M 611M 556M 1.05B 71.44B 1.05B 7.22B 2.81B 36.34B 2.83B 2.77B 121B 5.56B 827M 713M 671M 611M 1.15B 78.5B 1.16B 7.93B 3.09B 39.93B 3.11B 3.04B 132B
Net income 395M 58.71M 50.64M 47.64M 43.4M 81.61M 5.57B 82.05M 563M 219M 2.83B 220M 216M 9.4B 472M 70.16M 60.52M 56.93M 51.86M 97.53M 6.66B 98.05M 673M 262M 3.39B 263M 258M 11.23B
Net Debt - -
Logo Sinocare Inc.
Sinocare Inc is a China-based company primarily engaged in providing chronic disease testing products and health management services to chronic disease patients and medical institutions. The Company’s main products include blood glucose monitoring systems, diabetes nutrition and nursing support products, lipid profile monitoring systems, intelligent point-of-care (iPOCT) monitoring systems, glycated hemoglobin testing systems, blood pressure monitors and others. The Company is also engaged in providing systematic chronic disease assessments, standardized treatments, comprehensive in-hospital and out-of-hospital health management, knowledge education, and psychological counseling services to patients with metabolic diseases such as diabetes, obesity, and hyperuricemia. The Company conducts its business in the domestic and overseas markets.
Employees
4,994
Date Price Change Volume
26-09-01 CN¥16.08 +0.75% 3,354,397
26-08-31 CN¥15.96 -0.75% 2,897,032
26-08-28 CN¥16.08 -0.31% 2,404,557
26-08-27 CN¥16.13 -0.31% 2,751,100
26-08-26 CN¥16.18 -0.86% 3,294,130
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
16.08CNY
Average target price
22.88CNY
Spread / Average Target
+42.29%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 300298 Stock